We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIB
401
Trinity Biotech
TRIB
$5.7M
| $10.4M | 0.01% |
10,012
-400
| -4% | -$413K |
|
402
Titan Machinery
TITN
$466M
| $10.2M | 0.01% |
698,570
-28,270
| -4% | -$337K |
|
403
First Solar
FSLR
$21.8B
| $10.1M | 0.01% |
315,494
-62,517
| -17% | -$2.19M |
|
|
ARC
404
DELISTED
ARC Document Solutions, Inc.
ARC
| $10.1M | 0.01% |
1,984,853
-312,232
| -14% | -$1.31M |
|
405
Safety Insurance
SAFT
$1.52B
| $9.86M | 0.01% |
133,780
+1,757
| +1% | +$123K |
|
|
ISBC
406
DELISTED
Investors Bancorp, Inc.
ISBC
| $9.79M | 0.01% |
701,919
-281,776
| -29% | -$3.68M |
|
|
MTGE
407
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $9.53M | 0.01% |
606,882
+65,064
| +12% | +$1.08M |
|
|
XOG
408
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $9.46M | 0.01% |
+471,800
| New | +$10M |
|
409
NorthWestern Energy
NWE
$4.48B
| $9.39M | 0.01% |
165,190
+48,280
| +41% | +$2.72M |
|
|
BHI
410
DELISTED
Baker Hughes
BHI
| $9.31M | 0.01% |
143,228
-34,052
| -19% | -$2.02M |
|
411
Liberty Broadband Class C
LBRDK
$4.15B
| $9.3M | 0.01% |
125,626
-162
| -0.1% | -$11.4K |
|
412
Ceco Environmental
CECO
$4.42B
| $9.26M | 0.01% |
663,452
+10,385
| +2% | +$127K |
|
|
LHCG
413
DELISTED
LHC Group LLC
LHCG
| $9.16M | 0.01% |
200,554
+2,345
| +1% | +$95.3K |
|
|
ALE
414
DELISTED
Allete
ALE
| $9.07M | 0.01% |
141,275
-2,730
| -2% | -$167K |
|
|
BELFB
415
Bel Fuse Inc Class B
BELFB
$3.88B
| $9.04M | 0.01% |
292,570
+7,755
| +3% | +$216K |
|
|
AGN
416
DELISTED
Allergan plc
AGN
| $8.97M | 0.01% |
42,708
+21,508
| +101% | +$4.46M |
|
|
BV
417
DELISTED
Bazaarvoice, Inc.
BV
| $8.87M | 0.01% |
1,829,619
+797,040
| +77% | +$4.06M |
|
|
CSFL
418
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $8.86M | 0.01% |
352,143
-30,168
| -8% | -$642K |
|
|
QADA
419
DELISTED
QAD Inc.
QADA
| $8.82M | 0.01% |
290,200
+27,580
| +11% | +$724K |
|
|
IPHS
420
DELISTED
Innophos Holdings, Inc.
IPHS
| $8.81M | 0.01% |
168,646
+4,576
| +3% | +$222K |
|
421
Petrobras Class A
PBR.A
$107B
| $8.81M | 0.01% |
1,000,000
| – | – |
|
422
James River Group Holdings
JRVR
$218M
| $8.71M | 0.01% |
209,711
+5,642
| +3% | +$219K |
|
423
Matrix Service
MTRX
$347M
| $8.6M | 0.01% |
378,900
-75,200
| -17% | -$1.5M |
|
|
HOUS
424
DELISTED
Anywhere Real Estate
HOUS
| $8.6M | 0.01% |
334,211
+25,503
| +8% | +$631K |
|
425
iShares Russell 2000 Value ETF
IWN
$14.4B
| $8.51M | 0.01% |
71,509
-1,191
| -2% | -$132K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.